BIOMAT Database Logo BIOMAT Database Logo

[Type III hyperlipoproteinemia. A review and clinical and biochemical findings in 11 patients]. 1980

O Faergeman, and H Meinertz

UI MeSH Term Description Entries
D006952 Hyperlipoproteinemia Type III An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides. Autosomal Recessive Hypercholesterolemia,Broad Beta Disease,Dysbetalipoproteinemia,Dysbetalipoproteinemia, Familial,Familial Dysbetalipoproteinemia,Familial Hypercholesterolemia with Hyperlipemia,Hypercholesterolemia, Autosomal Recessive,Hyperlipoproteinemia, Broad-beta,Hyperlipoproteinemia, Type III,Autosomal Recessive Hypercholesterolemias,Broad-beta Hyperlipoproteinemia,Hyperlipoproteinemia, Broad beta,Hyperlipoproteinemias, Type III,Recessive Hypercholesterolemia, Autosomal,Type III Hyperlipoproteinemia,Type III Hyperlipoproteinemias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002994 Clofibrate A fibric acid derivative used in the treatment of HYPERLIPOPROTEINEMIA TYPE III and severe HYPERTRIGLYCERIDEMIA. (From Martindale, The Extra Pharmacopoeia, 30th ed, p986) Athromidin,Atromid,Atromid S,Clofibric Acid, Ethyl Ester,Ethyl Chlorophenoxyisobutyrate,Miscleron,Miskleron,Chlorophenoxyisobutyrate, Ethyl
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

O Faergeman, and H Meinertz
The biochemical, clinical, and genetic features of type III hyperlipoproteinemia.
February 1975, Annals of internal medicine,
O Faergeman, and H Meinertz
Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.
May 1993, The Clinical investigator,
O Faergeman, and H Meinertz
Type III hyperlipoproteinemia.
April 2002, Clinical cardiology,
O Faergeman, and H Meinertz
[Clinical and diagnostic aspects of type III hyperlipoproteinemia].
July 1979, Harefuah,
O Faergeman, and H Meinertz
[Hyperlipoproteinemia type III. Diagnostic possibilities and clinical picture].
January 1983, Vojnosanitetski pregled,
O Faergeman, and H Meinertz
[Hyperlipoproteinemia in out-patients. Occurrence, type distribution and correlation to clinical findings].
March 1973, Deutsche medizinische Wochenschrift (1946),
O Faergeman, and H Meinertz
Myelomatosis with type III hyperlipoproteinemia: clinical and metabolic studies.
July 1982, The New England journal of medicine,
O Faergeman, and H Meinertz
[Familial hyperlipoproteinemia type III].
November 1992, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
O Faergeman, and H Meinertz
[Familial type III hyperlipoproteinemia].
July 2007, Nihon rinsho. Japanese journal of clinical medicine,
O Faergeman, and H Meinertz
[Familial type III hyperlipoproteinemia].
March 2001, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!